CSIMarket
 
Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

Oramed Pharmaceuticals Inc Cash flow Statement Quarterly

ORMP



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Feb 28 2018)
6 Months
(Nov 30 2017)
3 Months
(Aug 31 2017)
12 Months
(May 31 2017)
9 Months
(Feb 28 2017)
6 Months
Income -5.45 -2.53 -10.48 7.78 -5.82
Depreciation & amortization 0.00 0.00 0.01 0.00 0.00
Amortization of Other Assets - - - - -
Increase (Decrease) in Deferred Revenue -1.22 -0.61 1.52 2.14 2.76
Restructuring & Impairment Charges - - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets - - - - -
Employee Benefits and Share-based Compensation 0.90 0.55 1.65 0.69 0.53
Income (Loss) from Equity Method Investments - - - - -
Foreign Currency Transaction Gain (Loss), before Tax, Total 0.11 -0.07 0.12 -0.11 -0.06
Issuance Of Stock And Warrants To Be Issued For Services Or Claims - - - - -
Imputed Interest Expense - - - - -
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities - - - - -
Warrants Exchanged - - - - -
Increase Decrease In Prepaid Expenses Other Current Assets And Related Parties Current - - -0.29 -0.29 0.02
Exchange Of Warrants - - - - -
Noncash Merger Related Costs 0.05 -0.23 - - -
Noncash Expense For Acquired Inprocess Research And Development - - - - -
Changes At Fair Value Of Investments - - - - -
Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement - - - - -
Increase Decrease In Operating Lease Liability - - - - -
Income taxes - - - - -
Gain (Loss) on Sale of Investments - - - - -
Increase (Decrease) in Employee Related Liabilities - - - - -
Increase (Decrease) in Accounts Payable and Accrued Liabilities -0.45 -0.04 1.26 1.13 1.03
Increase (Decrease) in Pension and Postretirement Obligations 0.00 0.00 0.00 0.00 0.00
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets - - - - -
Other Working Capital -0.04 -0.02 0.05 0.07 0.09
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities 0.00 - - -15.57 0.00
Discontinued operations - - - - -
Net Cash flow from Operating Activities -6.20 -2.73 -5.83 -3.78 -1.43
Capital Expenditures 0.00 - -0.01 -0.01 0.00
Sale of Capital Items - - - - -
Short-term Investments Proceeds 8.07 1.27 25.41 15.20 9.74
Payments to Acquire Held-to-maturity Securities -2.88 -2.88 -3.87 -2.90 -2.09
Real Estate Investments - - - - -
Payments To Acquire Funds In Respect Of Employee Rights Upon Retirement - - 0.00 - -
Funds In Respect Of Employee Rights Upon Retirement - - - - -
Payments To Acquire Mutual Funds - - - - -
Payments Of Corporate Bonds Designated As Fair Value - - - - -
Proceeds From Funds In Respect Of Employee Rights Upon Retirement - - - - -
Increase (Decrease) in Restricted Cash - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments to Acquire Long-term Investments -5.54 -3.54 -17.23 -11.00 -9.00
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Proceeds from Sale of Equity Method Investments - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - 0.00
Other Net 0.00 0.00 0.00 - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities -0.35 -5.15 4.30 1.29 -1.35
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments - - - - -
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock 4.88 4.23 0.03 - -
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net - - 0.00 - -
Proceeds From Receipts On Account Of Shares Issuances - - - - -
Proceeds From Stock Options And Warrants Exercised 0.32 0.32 - - 0.16
Proceeds From Exercise Of Warrants And Options - - 1.34 1.29 -
Interest Received - - - - -
E F F E C T O F E X C H A N G E R A T E C H A N G E S O N C A S H - - - - -
Proceeds From Issuance Of Common Stock And Warrants - - - - -
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents - - - - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 5.88 5.16 1.59 0.32 0.32
Effect of exchange rate on cash flow 0.00 0.00 0.01 0.00 0.00
Discontinued operations - - - - -
Free Cash Flow -6.21 -2.73 -5.84 -3.79 -1.43
Total Cash Flow -0.67 -2.71 0.06 -2.17 -2.46
Cash & cash equiv. at beg. of the Year 3.97 3.97 3.91 3.91 3.91
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid - - - - -




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com